BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Treatment
26 results:

  • 1. 8-Hydroxydaidzein Induces Apoptosis and Inhibits AML-Associated Gene Expression in U-937 Cells: Potential Phytochemical for AML treatment.
    Wu PS; Wang CY; Hsu HJ; Yen JH; Wu MJ
    Biomolecules; 2023 Oct; 13(11):. PubMed ID: 38002257
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Critical role of MXRA7 in differentiation blockade in human acute promyelocytic leukemia cells.
    Sun Z; Lin D; Shen Y; Ma K; Wang B; Liu H; Chen S; Wu D; Wang Y
    Exp Hematol; 2023; 125-126():45-54. PubMed ID: 37419299
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Two pediatric oncologic cases of hypereosinophilic syndrome and review of the literature.
    Voeller J; DeNapoli T; Griffin TC
    Cancer Rep (Hoboken); 2022 Nov; 5(11):e1710. PubMed ID: 36241191
    [TBL] [Abstract] [Full Text] [Related]  

  • 4.
    Kayabasi C; Yilmaz Susluer S; Balci Okcanoglu T; Ozmen Yelken B; Mutlu Z; Goker Bagca B; Caliskan Kurt C; Saydam G; Durmuskahya C; Kayalar H; Ozbilgin A; Biray Avci C; Gunduz C
    Nutr Cancer; 2022; 74(10):3679-3691. PubMed ID: 35608652
    [No Abstract]    [Full Text] [Related]  

  • 5. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma.
    Ishio T; Kumar S; Shimono J; Daenthanasanmak A; Dubois S; Lin Y; Bryant B; Petrus MN; Bachy E; Huang DW; Yang Y; Green PL; Hasegawa H; Maeda M; Goto H; Endo T; Yokota T; Hatanaka KC; Hatanaka Y; Tanaka S; Matsuno Y; Yang Y; Hashino S; Teshima T; Waldmann TA; Staudt LM; Nakagawa M
    Blood; 2022 Mar; 139(10):1541-1556. PubMed ID: 34818414
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Health care utilisation following childhood acute lymphoblastic leukaemia: a population-based matched cohort study.
    Jensen KS; Klug Albertsen B; Schrøder H; Zalounina Falborg A; Schmiegelow K; Rosthøj S; Callesen MT; Vedsted P
    BMJ Open; 2021 Nov; 11(11):e049847. PubMed ID: 34810184
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Regionalization of Acute Myeloid leukemia treatment in a Community-Based Population: Implementation and Early Results.
    Law LY; Uong SP; Vempaty HT; Nguyen VH; Baer D; Liu VX; Herrinton LJ
    Perm J; 2021 May; 25():. PubMed ID: 33970088
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Inhibition of CDK4/6 and autophagy synergistically induces apoptosis in t(8;21) acute myeloid leukemia cells.
    Nakatani K; Matsuo H; Harata Y; Higashitani M; Koyama A; Noura M; Nishinaka-Arai Y; Kamikubo Y; Adachi S
    Int J Hematol; 2021 Feb; 113(2):243-253. PubMed ID: 33068248
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on
    Silvestri G; Trotta R; Stramucci L; Ellis JJ; Harb JG; Neviani P; Wang S; Eisfeld AK; Walker CJ; Zhang B; Srutova K; Gambacorti-Passerini C; Pineda G; Jamieson CHM; Stagno F; Vigneri P; Nteliopoulos G; May PC; Reid AG; Garzon R; Roy DC; Moutuou MM; Guimond M; Hokland P; Deininger MW; Fitzgerald G; Harman C; Dazzi F; Milojkovic D; Apperley JF; Marcucci G; Qi J; Polakova KM; Zou Y; Fan X; Baer MR; Calabretta B; Perrotti D
    Blood Cancer Discov; 2020 Jul; 1(1):48-67. PubMed ID: 32974613
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic value of platelet recovery degree before and after achieving minimal residual disease negative complete remission in acute myeloid leukemia patients.
    Wang Y; Wang H; Wang W; Liu W; Liu N; Liu S; Lu Y
    BMC Cancer; 2020 Aug; 20(1):732. PubMed ID: 32758189
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Incidence of and Risk Factors for Histologically Confirmed Solid Benign Tumors Among Long-term Survivors of Childhood Cancer.
    Kok JL; Teepen JC; van der Pal HJ; van Leeuwen FE; Tissing WJE; Neggers SJCMM; Loonen JJ; Louwerens M; Versluys B; van den Heuvel-Eibrink MM; van Dulmen-den Broeder E; Jaspers MMW; van Santen HM; van der Heiden-van der Loo M; Janssens GO; Maduro JH; Bruggink AH; Jongmans MC; Kremer LCM; Ronckers CM;
    JAMA Oncol; 2019 May; 5(5):671-680. PubMed ID: 30920605
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Recurrent
    Matsuo H; Yoshida K; Fukumura K; Nakatani K; Noguchi Y; Takasaki S; Noura M; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Shiba N; Yamato G; Handa H; Ono Y; Hiramoto N; Ishikawa T; Usuki K; Ishiyama K; Miyawaki S; Itonaga H; Miyazaki Y; Kawamura M; Yamaguchi H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Hayashi Y; Mano H; Miyano S; Kamikubo Y; Ogawa S; Adachi S
    Blood Adv; 2018 Nov; 2(21):2879-2889. PubMed ID: 30381403
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.
    Martinez-Soria N; McKenzie L; Draper J; Ptasinska A; Issa H; Potluri S; Blair HJ; Pickin A; Isa A; Chin PS; Tirtakusuma R; Coleman D; Nakjang S; Assi S; Forster V; Reza M; Law E; Berry P; Mueller D; Osborne C; Elder A; Bomken SN; Pal D; Allan JM; Veal GJ; Cockerill PN; Wichmann C; Vormoor J; Lacaud G; Bonifer C; Heidenreich O
    Cancer Cell; 2018 Oct; 34(4):626-642.e8. PubMed ID: 30300583
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Impact of an animal-assisted therapy programme on physiological and psychosocial variables of paediatric oncology patients.
    Silva NB; Osório FL
    PLoS One; 2018; 13(4):e0194731. PubMed ID: 29617398
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Genetic abnormalities in core binding factor acute myeloid leukemia].
    Ishikawa Y
    Rinsho Ketsueki; 2017; 58(8):991-998. PubMed ID: 28883285
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.
    Shah V; Sherborne AL; Walker BA; Johnson DC; Boyle EM; Ellis S; Begum DB; Proszek PZ; Jones JR; Pawlyn C; Savola S; Jenner MW; Drayson MT; Owen RG; Houlston RS; Cairns DA; Gregory WM; Cook G; Davies FE; Jackson GH; Morgan GJ; Kaiser MF
    Leukemia; 2018 Jan; 32(1):102-110. PubMed ID: 28584253
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. RIC versus MAC UCBT in adults with AML: A report from Eurocord, the ALWP and the CTIWP of the EBMT.
    Baron F; Ruggeri A; Beohou E; Labopin M; Sanz G; Milpied N; Michallet M; Bacigalupo A; Blaise D; Sierra J; Socié G; Cornelissen JJ; Schmid C; Giebel S; Gorin NC; Esteve J; Ciceri F; Savani BN; Mohty M; Gluckman E; Nagler A
    Oncotarget; 2016 Jul; 7(28):43027-43038. PubMed ID: 27250025
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
    Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
    Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. GSTT1 and GSTM1 polymorphisms predict treatment outcome for acute myeloid leukemia: a systematic review and meta-analysis.
    Xiao Q; Deng D; Li H; Ye F; Huang L; Zhang B; Ye B; Mo Z; Yang X; Liu Z
    Ann Hematol; 2014 Aug; 93(8):1381-90. PubMed ID: 24994605
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Leukemogenesis as a new approach to investigate the correlation between up regulated gene 4/upregulator of cell proliferation (URG4/URGCP) and signal transduction genes in leukemia.
    Dodurga Y; Oymak Y; Gündüz C; Satıroglu-Tufan NL; Vergin C; Cetingül N; Biray Avci C; Topçuoğlu N
    Mol Biol Rep; 2013 Apr; 40(4):3043-8. PubMed ID: 23266667
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.